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ABSTRACT
The increasing demand for non-invasive (or less–invasive) monitoring and treatment of medical
conditions has attracted both physicians and engineers to work together and investigate new
methodologies. Wireless capsule endoscopy is a successful example of such techniques which has
become an accepted routine for diagnostic inspection of the gastrointestinal tract. This method
offers a non-invasive alternative to traditional endoscopy and provides the opportunity for
exploring distal areas of the small intestine which are otherwise not accessible. Despite these
advantages, wireless capsule endoscopy is still limited in functionality compared to traditional
endoscopy. Wireless capsule endoscopes with advanced functionalities, such as biopsy or drug
delivery, are highly desirable. In this article, the current status of wireless capsule endoscopy is
reviewed together with some of its possible therapeutic applications as well as the existing
challenges.
Keywords: wireless capsule endoscopy, ingestible medical device, in-body medical device,
medical robot, surgical robotics
1. INTRODUCTION
Annually, over 60 million people in the US alone are affected by digestive diseases,
accounting for about 10 percent of hospitalization and 15 percent of in-patient hospital
procedures in the US [1]. Despite advances in medical technology, diagnosis of the
cause of the disease remains a mystery in many of these cases. This is mainly due to the
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limited accessibility of the gastrointestinal (GI) tract, particularly the small intestine,
making it difficult to examine the underlying causes non-operatively. Moreover,
commonly used investigational techniques addressing the digestive tract are invasive
and/or impose a tremendous amount of discomfort to the patient.
Wireless capsule endoscopy, introduced in 2000 by Iddan et al. [2], suggests a non-
invasive alternative for inspection of the GI tract. In this method, an electronic pill
equipped with a miniature camera is swallowed by the patient. The pill collects images
of the digestive tract and wirelessly transmits them to an external device (Figure 1).
Extracted images may be viewed in real time [3] or saved into a personal computer [2]
for post-processing and analysis. The capsule is then expelled from the body through
the natural discharge process.
Wireless capsule endoscopy does not cause discomfort as in the traditional
endoscopy, and provides the opportunity for exploring distal areas of the small intestine.
This could lead to early diagnosis of GI disorders. However, wireless capsule
endoscopy is still limited in functionality compared to traditional endoscopy. Wireless
ingestible devices with advanced functionalities such as biopsy and drug delivery, can
greatly enhance the diagnosis and treatment of GI disorders and are highly sought after.
In this article, we review the current status of capsule endoscopy from a technological
point of view, present some of its possible therapeutic applications, and discuss the
existing challenges.  
Figure 1. Operational principle of a wireless capsule endoscope.
2. SYSTEM OVERVIEW
A conceptual diagram of a wireless capsule endoscope is illustrated in Figure 2. The
system includes several core components: an energy source, a processing/control unit, a
wireless communication unit, and sensors/actuators. The processing/control unit is the
brain of the system and controls the internal operations of the device. Sensors and
actuators act as interfaces between the device and body environment. The device can
monitor physiological parameters of the body through its sensors and perform therapeutic
actions through its actuators. The device communicates with outside the body through a
Radio Frequency (RF) link. This enables data exchange between the capsule and the
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external control unit, extraction of the physiological parameters of the body, and control
of the device operation. An energy source is needed to power various modules of the
device. Details of these components are discussed in the following sections. 
Figure 2. Conceptual schematic of a wireless capsule endoscope. 
2.1. Sensors and Actuators
Similar to all other medical conditions, monitoring of related physiological parameters
is the first step towards the successful diagnosis of GI disorders. Visual inspection of
the GI tract and measurement of temperature, pH value, and pressure are some of the
most common methods for detection of GI disorders [4, 5]. The history of remote
monitoring of physiological parameters along the digestive tract dates back to 1957
when the first ingestible capsules for measurement of pH value were developed [6].
Since then, several wireless ingestible capsules for monitoring of physiological
parameters were developed. SmartPill by SmartPill Corporation (New York, USA) [7]
is a commercial example of such devices and has gained FDA approval to aid in the
evaluation of gastrointestinal disorders. Wireless capsule endoscope introduced by
Iddan et al. [2] is another successful example of  such devices and has become the ‘gold
standard’ for investigating obscure gastrointestinal bleeding and iron-deficiency anemia
[8]. PillCam™ SB, PillCam™ ESO,  and PillCam™ COLON by Given Imaging
(Yoqneam, Israel) [9], EndoCapsule™ by Olympus (Tokyo, Japan) [10], MiroCam™
by IntroMedic (Seoul, Republic of Korea) [11], and OMOM by Chongqing Jinshan
Science and Technology Group (Chongqing, China) [12] are some of the wireless
capsule endoscopes currently used for inspecting various regions of the GI tract,
including small intestine, esophagus, and colon.
Although proven effective for diagnosis of some medical conditions, application of
sensors alone for monitoring body parameters provides limited capability and must be
usually accompanied by other more-invasive procedures to complete the diagnosis or
treatment process. For example, a confirmatory biopsy may be needed after detection
of a suspicious lesion through capsule endoscopy. Development of tissue-interactive
devices, such as ingestible capsules for drug delivery [13, 14] and body tissue/fluid
sampling [15, 16], is a necessary step towards less invasive solutions for treatment of
GI conditions. This is only achievable through integration of actuators in the system.
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Actuators may help performing therapy or improving the diagnosis. In section 3, some
of the possible actuation mechanisms for wireless capsule endoscopes are presented.
2.2. Control Unit
The control unit controls the operation of various capsule modules and performs desired
tasks through proper activation of the sensors and actuators. To this end, an intelligent
control unit is embedded in the system through implementation of necessary hardware
and software platforms. 
The use of “Commercially available Off-The-Shelf” (COTS) components or
application-specific integrated circuits (ASICs) technologies are common approaches
for the fabrication of the hardware platforms. ASICs provide a dedicated solution with
possibly superior performance, smaller size, and lower power consumption, while
COTS components offer a less expensive and fast-to-the-market solution for simple
applications. 
2.3. Wireless Communication Unit
Wireless communication with a control unit outside the human body is an essential
requirement for wireless capsule endoscopes.  This enables data exchange between the
capsule and the external control unit, control of the operation of the device, and
extraction of physiological parameters of the body.
Large signal attenuation by the body and the stringent size and energy constrains
make the development of an efficient wireless communication module for ingestible
devices a very challenging task. The wireless communication unit must be small
enough so that it can fit into a capsule that could be swallowed by the patient. It must
consume low electric power so that it can last long enough to perform useful operations
in the digestive tract. Moreover, it should not impose any threat or adverse effect to the
human body. For example, generation of heat and electrical current due to transmission
of electromagnetic signals should not exceed the regulatory standards [17]. This limits
the available range of communication frequency bands for these applications.
Several licensed frequency bands exist specifically for medical applications. The
transmission frequency and antenna design are mainly determined by the application.
Devices with low bandwidth and data rate can be based on near field transmission (e.g.,
inductive coupling), while devices with high bandwidth and data rate requirements use
radio frequencies. Most of the telemetry-based capsules work in the 402-405 MHz
Medical Implant Communication Services (MICS) band [18] or the 433/868/915 MHz
Industrial, Scientific and Medical (ISM) band [19], while some employ the 2.4 GHz
ISM band [20]. The 2.4 GHz wireless band provides the opportunity of reducing the
sizes of antenna and electronic chips and increasing the data rate, at the cost of
increased absorption rate and signal attenuation by the body. 
Proper choice of communication protocols, modulation techniques, and antenna
design are some of the other important factors that can greatly affect the performance
of the communication link [21, 22]. Application-specific modulation techniques [23,
24], communication protocols such as medium access control (MAC) protocol [25, 26],
and antenna designs [27, 28] for ingestible capsules to improve the communication
efficiency and reduce the power consumption are reported in the literature.
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2.4. Energy Source
Proper functionality of a wireless capsule endoscope relies on a continuous supply of
sufficient power. In this sense, a reliable, safe and convenient energy source is
imperative.
Currently, wireless capsule endoscopes use electrochemical batteries as their energy
source. Electrochemical batteries are relatively large and take almost half of the
available space in the capsule. This greatly affects the energy budget of the system and
consequently its functionality. Current batteries capacity can sustain capsule’s operation
for about 8 hours [29]. It is highly desired to extend capsule’s lifetime by increasing its
energy capacity. Moreover, extending this limitation paves the way for employment of
devices with high energy consumptions, such as motors and Shape Memory Alloy
(SMA) actuators. 
Inductive powering suggests a good alternative for ingestible capsules [30].
However, unpredictable orientation and location of the receiver make the design of a
dedicated inductive powering system a very challenging task [31]. Misalignment of
transmitting and receiving coils could significantly decrease the transmission efficiency
or even result in no received power. To enhance the efficiency and avoid zero crossing
in the power output, multiple primary or secondary coils may be employed [31].
Lenaerts et al. [32] developed an inductive power link based on multiple air coils on the
receiver side and delivered up to 150 mW to the capsule. This system was further
improved and optimized by Carta et al. [33] with the introduction of a ferrite core. The
developed system had the double advantages of reducing the size of the receiving coil
set and almost doubling the received power within the same external field.
3. THERAPEUTIC CAPSULE ENDOSCOPY
As discussed earlier, current capsule endoscopes suffer from limited functionality.
Capsules with advanced functionalities such as active locomotion, body tissue/fluid
sampling, and drug delivery can significantly enhance the diagnostic and therapeutic
procedures and are highly desirable. In this section, research activities towards
therapeutic applications of the wireless capsule endoscopes are reviewed.
3.1. Active Locomotion
Commercial ingestible capsules are passive and move by peristalsis. This limits their
controllability and thus application for advanced diagnostic and therapeutic purposes.
For example, capsule endoscopy may miss the foci of the disease or an area of interest
due to fast and unpredictable movements of the capsule. On the other hand, slow
movement of the capsule would result in repeated images and waste of the battery
energy. Moreover, advanced operations such as body tissue/fluid sampling or
hemostasis of bleeding areas are not possible with uncontrolled motion. An active and
controllable locomotion could overcome these challenges and open the door for
development of systems with advanced functionalities. 
Various locomotion mechanisms for ingestible capsules have been proposed. Quirini
et al. [34] developed a legged locomotion mechanism using small brushless dc motors
(Figure 3). Experimental results demonstrated that the device could travel in the
digestive tract with a speed ranging between 10 and 40 mm/min. The capsule could
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travel a distance of 15 cm in about 5 minutes against peristalsis in a porcine colon [35].
Kim et al. reported a paddling-based mechanism for active movement of capsule
endoscope [36].  Using this mechanism, a mean velocity of 17 cm/min over 40 cm
inside the colon of a living pig was achieved.
Figure 3. Capsule with legged locomotion [34].
A propeller based solution, actuated by electromagnetic DC motors, was developed
by Tortora et al. [37]. It was demonstrated that the propelled capsule could move in all
directions in the gastric environment under the control of the endoscopist. A maximum
speed of 7 cm/s in any directions was achievable using this method. The development
was achieved within the frame of the Vector project [38].
Several other methods, such as earthworm-like micro robot [39], vibratory actuation
[40], and magnetic guidance [41], have also been investigated. In general, these
methods could be classified into two main categories: (1) externally-driven locomotion
mechanisms driven by direct force of an external control unit, such as a magnetic
generator, and (2) integrated locomotion mechanisms inside the capsule. Externally-
driven systems, such as magnetic capsules, are usually simpler in design and can save
the space inside the capsule by shifting the complexity towards the external control unit,
while integrated locomotion mechanisms are usually more complex, consume more
energy, and take more space. Both categories need further research before application
in wireless capsule endoscopes.
3.2. Body tissue/fluid sampling
Some diagnostic and therapeutic procedures require sampling or even removal of GI
tissue or fluids. This is currently performed through either endoscopy or exploratory
surgery. A wireless biopsy capsule that can acquire body tissue or fluid at specific
locations along the GI tract is highly desirable and has been investigated by several
research groups. 
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Kong et al. [15] proposed a rotational tissue-cutting razor mechanism. The system is
actuated by a torsion spring that is held by a paraffin block at its rotated position. The
mechanism is triggered by heating the paraffin block to its melting temperature (40 ºC)
using an electric coil, releasing the rotational razor. The razor cuts and holds a small
piece of the GI mucosa. The sampled tissue could be extracted after the capsule is
expelled from the body. The mechanism is housed in an enclosure measuring 10 mm in
diameter and 2 mm in thickness. 
Park et al. [16] developed a microspike biopsy tool. The micro-actuator, illustrated
in Figure 4, comprises three parts: a microspike for microbiopsy; an actuating part
implementing a slider-crank mechanism using a torsion spring; and a triggering
mechanism composed of a SMA heating wire and a polymer string. The microspike is
actuated when electric power is applied to the SMA heating wire. The generated heat
melts and breaks the string, and consequently releases the torsion spring. This results in
generation of a forward and backward movement of the microspike. The fabricated
microactuator is 10mm in diameter and 1.8mm in thickness.
Despite these developments, performing a biopsy in the GI tract using wireless
capsules remains a challenge. It is not a trivial task to keep the capsule in close contact
with the tissue in order to perform biopsy successfully. This necessitates a controllable
locomotion or stopping mechanism that could guide and stop the capsule at a specific
location.
Figure 4. A capsular endoscope equipped with a micro-actuator for microbiopsy
(a), and the micro-actuator in its initial state (b), maximum stroke state
(c) and return state (d)  [16].
3.3. Drug Delivery
Efficient delivery of drugs by ingestible capsule to target organs or body tissues can
significantly enhance the efficacy of therapeutic procedures. In the pharmaceutical
industry, there has been a significant interest in ingestible capsules that can execute
non-invasive drug delivery to selected sites of the human GI tract, in order to determine,
for example, drug absorption rate, during the early developmental stages of drugs. 
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Enterion capsule [42] by Phaeton Research is a commercial example of drug
delivery capsules (Figure 5). It is 11 mm in diameter, 32 mm in length, and able to carry
1 ml of drug in either powder or liquid form. Drugs are pushed out of a reservoir by a
helicoidal spring. The mechanism is activated by a low frequency magnetic field
generator that induces electrical current in a heating element. The generated heat breaks
a string that holds the helicoidal spring. This unlocks the spring and triggers the release
of the drug from the capsule. 
Figure 5. Enterion capsule for drug delivery [42].
Intelisite capsule [13] developed by Innovative Devices is another example of
commercial drug delivery systems. The capsule is 10 mm in diameter, 35 mm in length,
and with a capacity of 0.8 ml of drug solution. The system utilizes SMA wires to
generate a rotational motion which creates openings on the capsule and releases the drug. 
Several other drug delivery capsules such as controlled release capsule [43], High
Frequency (HF) capsule [44], Pulsincap capsule [45] have also been reported. The
controlled release capsule employs electrolytic cells to generate gas to push the piston
along the capsule. The HF capsule is activated by an RF pulse transmitted from an
external generator. The heat generated by the RF current melts a thread and unlocks a
needle. The needle pierces a latex balloon prefilled with liquid medication and releases
its content. The Pulsincap capsule is equipped with a hydrogel polymer plug which
expands upon contact with GI fluids and slowly slides off the capsule body, releasing
the stored drug into the GI tract. 
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3.4. Emerging Applications
Introduction of an intelligent system into the body using a wireless ingestible capsule
provides a great opportunity for monitoring and interacting with body environment less
invasively. This has lead to the development of new methodologies for diagnosis and
treatment of medical conditions. 
An ingestible weight management capsule for treatment of obesity is one of such
new applications [46]. The operational principle of this technique is illustrated in Figure
6. In this method, a volume-adjustable pill is swallowed by the patient. After the pill
enters the stomach, it increases its volume upon receiving a command from an external
control unit, and occupies the space in the stomach to induce the feeling of satiety in the
patient. The capsule stays in the stomach for a desired period of time. At the end of the
treatment period, the pill is deflated and removed from the body through the natural
discharge process. The proposed system suggests a good alternative to conventional
intragastric balloon (IGB) for treatment of obesity. This approach reduces the
discomfort and operational complications caused by the conventional IGBs and
provides an opportunity for adjusting the volume of the balloon wirelessly and on
demand.
Figure 6. Operational principle of a capsule for treatment of obesity.
An imaginary futuristic therapeutic capsule endoscope is depicted in Figure 7. A
futuristic capsule endoscope may be able to move around and explore desired areas
using an active locomotion mechanism and perform advanced diagnostic and
therapeutic actions such as tissue sampling or drug delivery.
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4. TECHNICAL CHALLENGES
Although current technologies can provide high processing capabilities, the
development of more advanced and functional ingestible devices remains a major
challenge due to several major constraints, most importantly in limited size and energy
budget.
Figure 7. An imaginary depiction of a future wireless capsule endoscope [47]. 
Miniaturization to obtain an ingestible capsule is a major challenge. The device
should be small enough so that it could be swallowed by the patient. Considering
dimensions of a typical human digestive system, the capsule must be limited to about 1
cm in diameter and 3 cm in length. This imposes a challenging restriction to the system
and renders the integration of advanced functional units, particularly mechanical
components, impractical due to their relatively large dimensions.
Energy is another major constraint for ingestible medical devices. As discussed
earlier, space is very limited in ingestible medical capsules. This includes the available
space for on-board energy sources, such as batteries, or energy receivers in the capsule.
It is highly desirable to upgrade energy capacity in order to extend the capsule lifetime
and to allow integration of functional modules with higher power consumptions such as
motors and SMA actuators. On the other hand, the energy issue can be addressed by
reducing power consumption of the capsule in operation. This necessitates
implementation of energy-efficient, ultra-low power circuit design techniques and
effective power management strategies.
Wireless communication through the human body is another major challenge for
wireless capsule endoscopy. High signal attenuation and distortion due to the high and
468 Therapeutic Capsule Endoscopy: Opportunities and Challenges
uneven signal absorption rate of the body poses a great challenge to implementation of
a reliable and robust communication link. Moreover, it significantly restricts the usable
operational frequency bands and thus the effective data rates. Communication protocols
must be energy efficient and implement necessary security and privacy features.
Biocompatibility of the capsule is also a challenge. The capsule should be able to
perform its intended functions without eliciting any undesirable local or systemic
adverse effects in the body. Moreover, it should be able to survive harsh environmental
conditions of the gastrointestinal tract. The capsule is usually encapsulated in a
biocompatible material. The encapsulation of contactless sensors, such as image and
temperature sensors, is relatively simple compared to the packaging of tissue-
interactive actuators or chemical sensors that need direct contact to the GI tissue or
fluids.
5. CONCLUSION
The demand for non-invasive methodologies for diagnosis and treatment of GI
disorders has motivated development of advanced wireless capsule endoscopy systems
with diagnostic and therapeutic functionalities. It is envisaged that the wireless capsule
endoscopy may most likely replace both diagnostic and interventional flexible
endoscopies in the future by providing more functionalities such as body tissue/fluid
sampling and drug delivery. The progress towards this goal is mainly focused on the
development of miniaturized ultra-low-power functional modules, as well as exploring
new methodologies for increasing capsule’s energy budget. Recent advances in wireless
transmission of data and energy via the human body and the successful manipulation of
capsule endoscopes using external magnetic fields have shown promising results for
leveraging the functionality of current capsule endoscopy systems. However, these
methods need to be further investigated before securing applications in practical
systems.
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